Results 281 to 290 of about 230,438 (387)

The Creation of a Weight of Evidence Scoring Database for Risk Factors for Adverse Impacts to Birth Outcomes Using Expert Elicitation

open access: yesBirth Defects Research, Volume 118, Issue 1, January 2026.
ABSTRACT Background Adverse birth outcomes are important public health measures and account for a substantial public health burden. There is considerable diversity of these health endpoints, as well as in the many factors suspected or recognized to increase their risk.
Paul J. Villeneuve   +18 more
wiley   +1 more source

Developing a Trauma-Informed Social Media Campaign to Disseminate Endometriosis-Specific Qualitative Art-Based Research Findings: Tutorial.

open access: yesJ Med Internet Res
Marshall K   +10 more
europepmc   +1 more source

Rare Presentation of a Viable Secondary Abdominal Ectopic Pregnancy in the Rudimentary Horn of a Bicornuate Uterus: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT An advanced abdominal in a rudimentary horn pregnancy is rare and difficult to diagnose, especially in late gestation. Accurate early recognition, multidisciplinary planning, and preoperative vascular interventions are critical. With precise surgical management, even in high‐risk scenarios, favorable maternal and neonatal outcomes can be ...
Shazia Fakhar   +4 more
wiley   +1 more source

Active surveillance of an endometriosis-related, hormone-responsive pelvic adenosarcoma during pregnancy: A case report. [PDF]

open access: yesGynecol Oncol Rep
Zaidan A   +6 more
europepmc   +1 more source

Methods of Engaging Interest‐Holders in Healthcare Evidence Syntheses: A Scoping Review

open access: yesCochrane Evidence Synthesis and Methods, Volume 4, Issue 1, January 2026.
ABSTRACT Introduction Engaging interest‐holders in health care evidence syntheses may make evidence syntheses more relevant, useful, and accessible. However, the best way(s) to engage interest‐holders within the evidence synthesis process remain unknown.
Alex Todhunter‐Brown   +30 more
wiley   +1 more source

Bevacizumab in ovarian cancer: Clinical data and predictive and prognostic biomarkers

open access: yesClinical and Translational Medicine, Volume 16, Issue 1, January 2026.
Evidence supporting bevacizumab in ovarian cancer and predictive biomarkers: highlighting opportunities to improve patient selection and advance personalised treatment strategies. Abstract Angiogenesis, driven by the vascular endothelial growth factor (VEGF)/VEGFR signalling axis under hypoxic conditions, is one of the hallmarks of ovarian cancer (OC),
Maria Rosaria Lamia   +6 more
wiley   +1 more source

Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies. [PDF]

open access: yesFront Immunol
Shifon S   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy